Literature DB >> 2064554

Altered distribution of basic fibroblast growth factor in diabetic retinopathy.

A Hanneken1, E de Juan, G A Lutty, G M Fox, S Schiffer, L M Hjelmeland.   

Abstract

Basic fibroblast growth factor (FGF) is a potent endothelial cell mitogen that has been proposed to play a role in proliferative diabetic retinopathy and other neovascular processes. Our understanding of the in vivo role of basic FGF in the pathogenesis of these disorders is limited. We studied the immunolocalization of basic FGF in 16 clinical cases of diabetic retinopathy to determine whether the normal retinal distribution of basic FGF changed during the development of diabetic retinopathy and correlated with the onset of retinal neovascularization. By using monoclonal and affinity-purified polyclonal antibodies against basic FGF and heparan sulfate proteoglycan (HSPG), we found that basic FGF colocalized with HSPG to vascular basement membranes. As the basement membranes thickened during the progression of diabetic retinopathy, the intraretinal stores of immunoreactive basic FGF and HSPG expanded. With the development of neovascularization, the colocalization of basic FGF and HSPG changed; HSPG localized to basement membranes, while basic FGF localized intracellularly, with only minimal basement membrane immunoreactivity. Incubations of the neovascular fronds with exogenous basic FGF demonstrated multiple HSPG glycosaminoglycan-binding sites for basic FGF, indicating that basic FGF had not been released from the matrix of neovascular fronds by heparitanase digestion.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2064554     DOI: 10.1001/archopht.1991.01080070117048

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  22 in total

1.  Long-term retention of dye after indocyanine green-assisted internal limiting membrane peeling.

Authors:  Masayuki Ashikari; Hironori Ozeki; Kazuyuki Tomida; Eiji Sakurai; Kazushi Tamai; Yuichiro Ogura
Journal:  Jpn J Ophthalmol       Date:  2006 Jul-Aug       Impact factor: 2.447

2.  Regulation of retinal capillary cells by basic fibroblast growth factor, vascular endothelial growth factor, and hypoxia.

Authors:  Q Yan; Y Li; A Hendrickson; E H Sage
Journal:  In Vitro Cell Dev Biol Anim       Date:  2001-01       Impact factor: 2.416

3.  Localisation of vascular endothelial growth factor and its receptors to cells of vascular and avascular epiretinal membranes.

Authors:  Y S Chen; S F Hackett; C L Schoenfeld; M A Vinores; S A Vinores; P A Campochiaro
Journal:  Br J Ophthalmol       Date:  1997-10       Impact factor: 4.638

4.  Angiogenic factors in human proliferative sickle cell retinopathy.

Authors:  J Cao; M K Mathews; D S McLeod; C Merges; L M Hjelmeland; G A Lutty
Journal:  Br J Ophthalmol       Date:  1999-07       Impact factor: 4.638

5.  Basic fibroblast growth factor is neither necessary nor sufficient for the development of retinal neovascularization.

Authors:  H Ozaki; N Okamoto; S Ortega; M Chang; K Ozaki; S Sadda; M A Vinores; N Derevjanik; D J Zack; C Basilico; P A Campochiaro
Journal:  Am J Pathol       Date:  1998-09       Impact factor: 4.307

6.  Growth factor staining patterns in the pig retina following retinal laser photocoagulation.

Authors:  M Xiao; D McLeod; J Cranley; G Williams; M Boulton
Journal:  Br J Ophthalmol       Date:  1999-06       Impact factor: 4.638

7.  Early photocoagulation in patients with either type I or type II diabetes.

Authors:  F Ferris
Journal:  Trans Am Ophthalmol Soc       Date:  1996

8.  VEGF localisation in diabetic retinopathy.

Authors:  M Boulton; D Foreman; G Williams; D McLeod
Journal:  Br J Ophthalmol       Date:  1998-05       Impact factor: 4.638

9.  Insulin-like growth factor I acts as an angiogenic agent in rabbit cornea and retina: comparative studies with basic fibroblast growth factor.

Authors:  M B Grant; R N Mames; C Fitzgerald; E A Ellis; M Aboufriekha; J Guy
Journal:  Diabetologia       Date:  1993-04       Impact factor: 10.122

10.  Histological evaluation of the canine retinal vasculature following chronic systemic administration of basic fibroblast growth factor.

Authors:  J L Jacot; N M Laver; J P Glover; D F Lazarous; E F Unger; W G Robison
Journal:  J Anat       Date:  1996-04       Impact factor: 2.610

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.